Trial Profile
Effect of Melatonin on Sleep Disturbances in Patients With Parkinson's Disease: Double Blind, Randomized, Placebo Controlled Trial
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 06 Nov 2021
Price :
$35
*
At a glance
- Drugs Melatonin (Primary)
- Indications Insomnia; REM-sleep-behavior-disorder; Sleep disorders
- Focus Therapeutic Use
- Sponsors Kuhnil Pharmaceutical Company
- 24 May 2016 New trial record